ENTITY
Nippon Shinyaku

Nippon Shinyaku (4516 JP)

47
Analysis
Health CareJapan
Nippon Shinyaku Co., Ltd. manufactures pharmaceutical and health foods products. The Company produces drugs for urinary, nerve, respiratory, and circulatory systems as well as analgesic and anti-inflammatory drugs. Nippon Shinyaku also develops synthetic anti-bacterial agents.
more
27 Apr 2018 17:01

Japan Pharmaceuticals: FY17e Earnings Preview (II)

Shionogi & Co Ltd (4507 JP) - May 09, 2018FY18e Potential GuidanceHIV franchise continues its growth trajectory, however, genericization of its...

20 Apr 2018 18:16

Japan Pharmaceuticals: The Week that Was…

Nippon Shinyaku Co Ltd (4516 JP) @ ¥ 8,480 (up ~18% week-to-date) vs. our TP ¥ 8,600. We recommend booking profit at current levels. Takeda...

13 Apr 2018 17:33

Japan Pharmaceuticals: The Week that Was…

Takeda Pharmaceutical Co Ltd (4502 JP) @ ¥ 4,911/ share (down 24% YTD) implies ~17x (~30% discount to industry average) our FY19e core EPS of ¥...

06 Apr 2018 13:44

Japan Pharma: Upcoming Catalysts & Event Driven Trading Ideas

Takeda Pharmaceutical Co Ltd (4502 JP), Shionogi & Co Ltd (4507 JP), Nippon Shinyaku Co Ltd (4516 JP) , Sumitomo Dainippon Pharma Co (4506 JP),...

03 Apr 2018 15:41

Japan Pharma - Drug Price Revision in April 2018

Japan, after the US and China, is the world’s third largest pharma industry, worth ~$70b in 2016. However, according to research and consulting...

x